Lindsay Pieper, CRNP Nurse Practitioner - Gerontology Medicare: Accepting Medicare Assignments Practice Location: 24980 State St, Elberta, AL 36530 Phone: 251-986-7301 Fax: 251-986-5927 |
Carolyn Faircloth Holman, C.R.N.P. Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 24980 State St, Po Drawer 519, Elberta, AL 36530 Phone: 251-986-7301 Fax: 251-986-5927 |
Kristy Beard, CRNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 30197 Gardner Rd, Elberta, AL 36530 Phone: 251-228-1113 |
Donna Susanne Heath, CRNP, ARNP, FNP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 9275 Bay Point Dr, Elberta, AL 36530 Phone: 205-401-0976 Fax: 251-265-3039 |
Mrs. Donna Mcinnis Beck, CRNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 24980 State St, Elberta, AL 36530 Phone: 251-986-7301 Fax: 251-986-5927 |
Ms. Debra Lynn Russell, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 24980 State Street, Po Drawer 519, Elberta, AL 36530 Phone: 251-986-7301 Fax: 251-986-5927 |
News Archive
University of Oregon scientists have identified brain cells vital to how zebrafish socialize. When the neurons are disabled, their orientation to one another breaks down in ways similar to socialization problems seen in humans with autism spectrum disorders and schizophrenia.
Mitt Romney's campaign is rebutting the Democratic National Committee's claims about his record on health reform and abortion rights.
MMI-USA, a subsidiary of Memometal Technologies S.A., a global orthopaedic manufacturer headquartered in France, announces the limited launch of the new Smart Toe® II Hammertoe Fixation System. The product becomes an important piece of a comprehensive system for forefoot fixation, and reinforces the most widely used franchise of intramedullary implants of this kind in the world.
The drug pazopanib (Votrient) slowed the progression of advanced renal cell carcinoma (RCC), a form of kidney cancer, in patients by 54% percent, according to a new study published in the Journal of Clinical Oncology.
Recurrence of HER2-positive breast cancer after treatment may be due to a specific and possibly cancer-induced weakness in the patient's immune system - a weakness that in principle could be corrected with a HER2-targeted vaccine - according to a new study from the Perelman School of Medicine at the University of Pennsylvania.
› Verified 7 days ago